Sponsored Links: Prescription Drug Addiction     PDF Download (4MB) May/June 2006 Proof of Concept: Pharma's New Watchwords Better tools and approaches finally bridge discovery and clinical trials. By Malorye A. Branca U.K. Drug Disaster Prompts Changes Early-phase antibody trials will get stricter review. PerkinElmer on a Proteomics Spree Deals bring out firm's competitive spirit. Briefings U.K. Drama Highlights MAb Pricing  Breast cancer patient wins her case, but what's next?  Outlook: Burrill on Today's Leading Bio-Opportunities Time for a New Business Model? By Peter Keeling Can Genasense Bounce Back? New subgroup analysis submitted with melanoma application. Apoptosis Field Springs to Life Will upsurge in targets and methods spell success? Pharma Prepares for Avian Flu Pandemic While skepticism reigns, pharma readies an array of new weapons just in case. Tech Brief: Synthetic Peptide Vaccine Against Pandemic H5N1 Infuenza Based on li-Key Modified MHC Class II Epitopes Essay: Insects Join the Flu Fight Caterpillars might help solve the chicken-and-egg problem common for vaccine manufacturers. Fragment-Based Drug Design Delivers  Novartis inks $1 billion in deals with FBDD companies.  Dealmakers: Major Pharma, Biotech, and Related Agreements Welcome Letter - New Launch, Old Friend New Products Email this page to a friend

Home | Contact Us | Subscribe | Privacy Policy THE CHI NETWORK Cambridge Healthtech Institute| Beyond Genome | Bio-IT World | Biomarker World Congress | Cambridge Health Associates | Discovery On Target |  Digital Healthcare & Productivity | Life Sciences Conference + Expo  | Molecular Medicine Tri-Conference | PEGSummit | PepTalk | PharmaWeek |  World Pharmaceutical Congress © 2006 Cambridge Healthtech Institute. All rights reserved. Reproduction in whole or in part is prohibited. Please send any technical comments or questions to our webmaster.